Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Chander

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Journal of Medicinal Chemistry|June 22, 2007
Dual aromatase-steroid sulfatase inhibitorsL W Lawrence Woo, Christian Bubert, Oliver B Sutcliffe, et al.
Journal of Medicinal Chemistry|February 13, 2010
Highly potent first examples of dual aromatase-steroid sulfatase inhibitors based on a biphenyl templateL W Lawrence Woo, Toby Jackson, Aurélien Putey, et al.
British Journal of Cancer|October 9, 2008
The in vivo properties of STX243: a potent angiogenesis inhibitor in breast cancerM F C Parsons, P A Foster, S K Chander, et al.
The Journal of Steroid Biochemistry and Molecular Biology|November 19, 2003
Steroid sulphatase inhibitors for breast cancer therapyA Purohit, L W L Woo, S K Chander, et al.
Chemmedchem|July 16, 2010
Bicyclic derivatives of the potent dual aromatase-steroid sulfatase inhibitor 2-bromo-4-{[(4-cyanophenyl)(4h-1,2,4-triazol-4-yl)amino]methyl}phenylsulfamate: synthesis, SAR, crystal structure, and in vitro and in vivo activitiesPaul M Wood, L W Lawrence Woo, Jean-Robert Labrosse, et al.
British Journal of Cancer|February 19, 2004
Pharmacokinetics and efficacy of 2-methoxyoestradiol and 2-methoxyoestradiol-bis-sulphamate in vivo in rodentsC R Ireson, S K Chander, A Purohit, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2008
A new therapeutic strategy against hormone-dependent breast cancer: the preclinical development of a dual aromatase and sulfatase inhibitorPaul A Foster, Surinder K Chander, Simon P Newman, et al.
Molecular and Cellular Endocrinology|January 18, 2006
The regulation and inhibition of 17beta-hydroxysteroid dehydrogenase in breast cancerA Purohit, H J Tutill, J M Day, et al.
British Journal of Cancer|June 25, 2014
In vivo and in vitro properties of STX2484: a novel non-steroidal anti-cancer compound active in taxane-resistant breast cancerC Stengel, S P Newman, J M Day, et al.
Clinical & Experimental Metastasis|March 1, 1997
Conversion of highly malignant colon cancer from an aggressive to a controlled disease by oral administration of a metalloproteinase inhibitorZ An, X Wang, N Willmott, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Journal of Medicinal Chemistry|June 22, 2007
Dual aromatase-steroid sulfatase inhibitorsL W Lawrence Woo, Christian Bubert, Oliver B Sutcliffe, et al.
Journal of Medicinal Chemistry|February 13, 2010
Highly potent first examples of dual aromatase-steroid sulfatase inhibitors based on a biphenyl templateL W Lawrence Woo, Toby Jackson, Aurélien Putey, et al.
British Journal of Cancer|October 9, 2008
The in vivo properties of STX243: a potent angiogenesis inhibitor in breast cancerM F C Parsons, P A Foster, S K Chander, et al.
The Journal of Steroid Biochemistry and Molecular Biology|November 19, 2003
Steroid sulphatase inhibitors for breast cancer therapyA Purohit, L W L Woo, S K Chander, et al.
Chemmedchem|July 16, 2010
Bicyclic derivatives of the potent dual aromatase-steroid sulfatase inhibitor 2-bromo-4-{[(4-cyanophenyl)(4h-1,2,4-triazol-4-yl)amino]methyl}phenylsulfamate: synthesis, SAR, crystal structure, and in vitro and in vivo activitiesPaul M Wood, L W Lawrence Woo, Jean-Robert Labrosse, et al.
British Journal of Cancer|February 19, 2004
Pharmacokinetics and efficacy of 2-methoxyoestradiol and 2-methoxyoestradiol-bis-sulphamate in vivo in rodentsC R Ireson, S K Chander, A Purohit, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2008
A new therapeutic strategy against hormone-dependent breast cancer: the preclinical development of a dual aromatase and sulfatase inhibitorPaul A Foster, Surinder K Chander, Simon P Newman, et al.
Molecular and Cellular Endocrinology|January 18, 2006
The regulation and inhibition of 17beta-hydroxysteroid dehydrogenase in breast cancerA Purohit, H J Tutill, J M Day, et al.
British Journal of Cancer|June 25, 2014
In vivo and in vitro properties of STX2484: a novel non-steroidal anti-cancer compound active in taxane-resistant breast cancerC Stengel, S P Newman, J M Day, et al.
Clinical & Experimental Metastasis|March 1, 1997
Conversion of highly malignant colon cancer from an aggressive to a controlled disease by oral administration of a metalloproteinase inhibitorZ An, X Wang, N Willmott, et al.
Pageof 7